The 11th Asia-Pacific League of Associations for Rheumatology Congress (APLAR 2004): JCR Sponsored Symposium “Efficacy and Safety of TNF-alpha Blockers in Rheumatoid Arthritis” September 12 (Sunday), 2004, 14:00-15:30, Jeju, Korea 1. Efficacy and safety of infliximab in the treatment of Japanese rheumatoid arthritis patients 2. Expression profile analysis by microarray to predict responders to anti-TNF biologics in rheumatoid arthritis 3. Biologicals in India - postmarketing surveillance: problems and prospects 4. Infliximab: the experience in Hong Kong 5. Postmarketing surveillance of etanercept in Australia up to June 2004 6. The open-label evaluation of the efficacy and safety of etanercept in patients with active rheumatoid arthritis and ankylosing spondylitis

Presents several abstracts related to the efficacy and safety of tumor necrosis factor (TNF)-alpha blockers in rheumatoid arthritis. Expression profile analysis by microarray to predict responders to anti-TNF biologics in rheumatoid arthritis; Postmarketing surveillance of etanercept in Australia; Open-label evaluation of the efficacy and safety of etanercept in patients with active rheumatoid arthritis and ankylosing spondylitis.